4//SEC Filing
LINDAHL RICHARD S 4
Accession 0001367644-25-000030
CIK 0001367644other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:05 PM ET
Size
8.4 KB
Accession
0001367644-25-000030
Insider Transaction Report
Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-02-28$7.48/sh−1,073$8,026→ 153,020 total - Tax Payment
Common Stock
2025-03-01$7.48/sh−683$5,109→ 152,337 total - Disposition to Issuer
Common Stock
2025-02-12−16,916→ 154,093 total
Footnotes (2)
- [F1]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. On February 12, 2025, the final certification date, the Compensation Committee certified the achievement of the 2022-2024 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 16,916 shares previously reported on March 1, 2022.
- [F2]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001196632
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:05 PM ET
- Size
- 8.4 KB